MassMutual Private Wealth & Trust’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
Other funds holding DNLI
MassMutual Private Wealth & Trust's DNLI Position: Q3 2026 in Review
MassMutual Private Wealth & Trust held its Denali Therapeutics (DNLI) position steady in Q3 2026 at 143 shares worth $2.96K. The position accounts for ﹤0.01% of the portfolio, ranked #1806.
MassMutual Private Wealth & Trust first reported a position in DNLI in Q1 2022 and has held it in 15 quarters since. The position peaked at $4.49K in Q3 2024. 287 funds tracked by Wall St. Rank hold DNLI as of Q3 2026.
- MassMutual Private Wealth & Trust held 143 shares of Denali Therapeutics worth $2.96K as of Q3 2026.
- MassMutual Private Wealth & Trust left its Denali Therapeutics share count unchanged in Q3 2026.
- Denali Therapeutics made up ﹤0.01% of MassMutual Private Wealth & Trust's portfolio in Q3 2026, its #1806 holding.
- MassMutual Private Wealth & Trust first reported a position in Denali Therapeutics in Q1 2022 and has held it in 15 quarters since.
- MassMutual Private Wealth & Trust's Denali Therapeutics position peaked at $4.49K in Q3 2024.
- 287 funds tracked by Wall St. Rank held Denali Therapeutics as of Q3 2026.
Based on MassMutual Private Wealth & Trust's 13F filing for Q3 2026, filed 5 Oct 2026.